Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (1-(((5r)-2-(4-(5-chloropyrimidin-2-yl)piperidin-1-yl)-5-oxo-6,7-dihydrothieno(3,2-d)pyrimidin-4-yl)amino)cyclobutyl)methanol
2. Bi 1015550
1. 1423719-30-5
2. Bi 1015550
3. Bi-1015550
4. Nerandomilast [inn]
5. I5dgt51ib8
6. Schembl25606332
7. Gtpl12518
8. Glxc-27143
9. Ex-a7747
10. Da-61644
11. Bi1015550
12. Hy-153192
13. Cs-0654251
14. Bi-1015550?
15. (r)-2-(4-(5-chloropyrimidin-2-yl)piperidin-1-yl)-4-((1-(hydroxymethyl)cyclobutyl)amino)-6,7-dihydrothieno[3,2-d]pyrimidine 5-oxide
16. [1-[[(5r)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]cyclobutyl]methanol
17. 1-[[(5r)-2-[4-(5-chloro-2-pyrimidinyl)-1-piperidinyl]-6,7-dihydro-5-oxidothieno[3,2-d]pyrimidin-4-yl]amino]cyclobutanemethanol
18. Cyclobutanemethanol, 1-[[(5r)-2-[4-(5-chloro-2-pyrimidinyl)-1-piperidinyl]-6,7-dihydro-5-oxidothieno[3,2-d]pyrimidin-4-yl]amino]-
| Molecular Weight | 449.0 g/mol |
|---|---|
| Molecular Formula | C20H25ClN6O2S |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 123 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 624 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
77
PharmaCompass offers a list of Nerandomilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nerandomilast manufacturer or Nerandomilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nerandomilast manufacturer or Nerandomilast supplier.
PharmaCompass also assists you with knowing the Nerandomilast API Price utilized in the formulation of products. Nerandomilast API Price is not always fixed or binding as the Nerandomilast Price is obtained through a variety of data sources. The Nerandomilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nerandomilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nerandomilast, including repackagers and relabelers. The FDA regulates Nerandomilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nerandomilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nerandomilast supplier is an individual or a company that provides Nerandomilast active pharmaceutical ingredient (API) or Nerandomilast finished formulations upon request. The Nerandomilast suppliers may include Nerandomilast API manufacturers, exporters, distributors and traders.
Nerandomilast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nerandomilast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nerandomilast GMP manufacturer or Nerandomilast GMP API supplier for your needs.
A Nerandomilast CoA (Certificate of Analysis) is a formal document that attests to Nerandomilast's compliance with Nerandomilast specifications and serves as a tool for batch-level quality control.
Nerandomilast CoA mostly includes findings from lab analyses of a specific batch. For each Nerandomilast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nerandomilast may be tested according to a variety of international standards, such as European Pharmacopoeia (Nerandomilast EP), Nerandomilast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nerandomilast USP).
